Published in J Clin Oncol on February 15, 2004
The EMPATHY Pilot Study | NCT04384848
Pain Monitoring After Breast Biopsy: Benefit of E-health (BIO-PSY) | NCT04456920
Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst (2009) 5.05
Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res (2009) 4.13
Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial. J Clin Oncol (2011) 3.62
Effects of screening for psychological distress on patient outcomes in cancer: a systematic review. J Psychosom Res (2013) 2.78
Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol (2011) 2.70
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. J Clin Oncol (2015) 2.19
Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities. J Am Med Inform Assoc (2007) 1.89
Harmonized patient-reported data elements in the electronic health record: supporting meaningful use by primary care action on health behaviors and key psychosocial factors. J Am Med Inform Assoc (2012) 1.87
Improving health care efficiency and quality using tablet personal computers to collect research-quality, patient-reported data. Health Serv Res (2008) 1.65
PatientViewpoint: a website for patient-reported outcomes assessment. Qual Life Res (2009) 1.64
Improving the care of children with advanced cancer by using an electronic patient-reported feedback intervention: results from the PediQUEST randomized controlled trial. J Clin Oncol (2014) 1.63
The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer (2006) 1.47
Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer. Psychooncology (2009) 1.44
Personal digital assistant data capture: the future of quality of life measurement in prostate cancer treatment. J Oncol Pract (2007) 1.39
Assessing responsiveness of generic and specific health related quality of life measures in heart failure. Health Qual Life Outcomes (2006) 1.38
A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res (2013) 1.38
Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. J Clin Oncol (2013) 1.34
Health-related quality of life and cancer clinical trials. Ther Adv Med Oncol (2011) 1.30
The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care. Med Care (2015) 1.28
Prospects and challenges in using patient-reported outcomes in clinical practice. Qual Life Res (2008) 1.26
The interface of primary and oncology specialty care: from diagnosis through primary treatment. J Natl Cancer Inst Monogr (2010) 1.24
Quality of life assessment in women with breast cancer: benefits, acceptability and utilization. Health Qual Life Outcomes (2007) 1.21
The Computer-based Health Evaluation Software (CHES): a software for electronic patient-reported outcome monitoring. BMC Med Inform Decis Mak (2012) 1.20
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer. Br J Cancer (2004) 1.20
A Rasch and factor analysis of the Functional Assessment of Cancer Therapy-General (FACT-G). Health Qual Life Outcomes (2007) 1.19
Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention. Br J Haematol (2009) 1.19
Review of electronic patient-reported outcomes systems used in cancer clinical care. J Oncol Pract (2013) 1.15
Quality of breast cancer care: perception versus practice. J Clin Oncol (2012) 1.15
Asking the right questions: investigating needs assessments and health-related quality-of-life questionnaires for use in oncology clinical practice. Support Care Cancer (2007) 1.14
Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012. Geburtshilfe Frauenheilkd (2013) 1.14
Feasibility and value of PatientViewpoint: a web system for patient-reported outcomes assessment in clinical practice. Psychooncology (2012) 1.14
Evaluation of a tablet PC technology to screen and educate oncology patients. Support Care Cancer (2007) 1.13
Patient-reported outcomes and survivorship in radiation oncology: overcoming the cons. J Clin Oncol (2014) 1.13
Psychological distress in parents of children with advanced cancer. JAMA Pediatr (2013) 1.13
Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trial. J Am Med Inform Assoc (2010) 1.11
Multilevel interventions: measurement and measures. J Natl Cancer Inst Monogr (2012) 1.10
Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales. Am J Gastroenterol (2014) 1.10
Effects of radiotherapy for brain metastases on quality of life (QoL). Prospective pilot study of the DEGRO QoL working party. Strahlenther Onkol (2009) 1.08
Management of gastrointestinal symptoms in advanced cancer patients: the rapid learning cancer clinic model. Curr Opin Support Palliat Care (2010) 1.08
Patient-reported outcomes in gastroenterology: clinical and research applications. J Neurogastroenterol Motil (2013) 1.07
Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial. J Clin Oncol (2013) 1.07
Using health communication best practices to develop a web-based provider-patient communication aid: the CONNECT study. Patient Educ Couns (2008) 1.05
Integrating a web-based, patient-administered assessment into primary care for HIV-infected adults. J AIDS HIV Res (2012) 1.04
Innovations in e-health. Qual Life Res (2013) 1.03
The problems experienced by patients with cancer and their needs for palliative care. Support Care Cancer (2005) 1.03
A review of quality of life instruments used in liver transplantation. J Hepatol (2009) 1.03
Electronic symptom reporting between patient and provider for improved health care service quality: a systematic review of randomized controlled trials. part 1: state of the art. J Med Internet Res (2012) 1.01
Do high symptom scores trigger clinical actions? An audit after implementing electronic symptom screening. J Oncol Pract (2012) 1.01
A randomized controlled pilot trial of the functional assessment screening tablet to engage patients at the point of care. J Gen Intern Med (2014) 1.00
Monitoring health-related quality of life in paediatric practice: development of an innovative web-based application. BMC Pediatr (2011) 1.00
Symptoms, supportive care needs, and function in cancer patients: how are they related? Qual Life Res (2008) 0.99
Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge. Mult Scler Int (2013) 0.97
Integrating Patient-Reported Outcome Measures into Routine Cancer Care: Cancer Patients' and Clinicians' Perceptions of Acceptability and Value. EGEMS (Wash DC) (2015) 0.97
Meeting the support and information needs of women with advanced breast cancer: a randomised controlled trial. Br J Cancer (2006) 0.97
A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery. Gynecol Oncol (2012) 0.97
Palliative care needs of cancer outpatients receiving chemotherapy: an audit of a clinical screening project. Support Care Cancer (2007) 0.97
Logistic feasibility of health related quality of life measurement in clinical practice: results of a prospective study in a large population of chronic liver patients. Health Qual Life Outcomes (2008) 0.96
The role of informatics in promoting patient-centered care. Cancer J (2011) 0.96
Living with muscular dystrophy: health related quality of life consequences for children and adults. Health Qual Life Outcomes (2007) 0.94
Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer. Br J Cancer (2012) 0.94
Feasibility test of a UK-scalable electronic system for regular collection of patient-reported outcome measures and linkage with clinical cancer registry data: the electronic Patient-reported Outcomes from Cancer Survivors (ePOCS) system. BMC Med Inform Decis Mak (2011) 0.94
Serial personal digital assistant data capture of health-related quality of life: a randomized controlled trial in a prostate cancer clinic. Health Qual Life Outcomes (2007) 0.94
Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician's attention. Qual Life Res (2013) 0.93
Physicians' knowledge of health-related quality of life and perception of its importance in daily clinical practice. Health Qual Life Outcomes (2010) 0.93
Preparing patients for threatening medical treatments: effects of a chemotherapy educational DVD on anxiety, unmet needs, and self-efficacy. Support Care Cancer (2007) 0.93
Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial. Clin Trials (2015) 0.93
Multidisciplinary health care professionals' perceptions of the use and utility of a symptom assessment system for oncology patients. J Oncol Pract (2011) 0.92
What can I do? Recommendations for responding to issues identified by patient-reported outcomes assessments used in clinical practice. J Support Oncol (2012) 0.92
Screening for social difficulties in cancer patients: clinical utility of the Social Difficulties Inventory. Br J Cancer (2007) 0.91
Patient-reported symptoms and quality of life integrated into clinical cancer care. Semin Oncol Nurs (2011) 0.91
Communicating patient-reported outcome scores using graphic formats: results from a mixed-methods evaluation. Qual Life Res (2015) 0.91
Do neurooncological patients and their significant others agree on quality of life ratings? Health Qual Life Outcomes (2009) 0.91
Implementation of improvement strategies in palliative care: an integrative review. Implement Sci (2015) 0.91
Moving towards patient-centered decision-making in chronic myeloid leukemia: assessment of quality of life and symptom burden. Haematologica (2014) 0.90
Communicating advanced cancer patients' symptoms via the Internet: a pooled analysis of two randomized trials examining caregiver preparedness, physical burden, and negative mood. Palliat Med (2012) 0.90
Feasibility and acceptance of electronic quality of life assessment in general practice: an implementation study. Health Qual Life Outcomes (2009) 0.90
The electronic self report assessment and intervention for cancer: promoting patient verbal reporting of symptom and quality of life issues in a randomized controlled trial. BMC Cancer (2014) 0.90
Electronic symptom reporting between patient and provider for improved health care service quality: a systematic review of randomized controlled trials. part 2: methodological quality and effects. J Med Internet Res (2012) 0.90
Patient-Reported Outcomes vs. Clinician Symptom Reporting During Chemoradiation for Rectal Cancer. Gastrointest Cancer Res (2012) 0.89
Assessment of palliative care cancer patients' most important concerns. Support Care Cancer (2010) 0.89
Automated monitoring of symptoms during ambulatory chemotherapy and oncology providers' use of the information: a randomized controlled clinical trial. Support Care Cancer (2014) 0.89
Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries. Orphanet J Rare Dis (2015) 0.88
Electronic Quality of Life Assessment Using Computer-Adaptive Testing. J Med Internet Res (2016) 0.88
An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients. Ecancermedicalscience (2016) 0.88
Changes in quality of life during palliative chemotherapy for solid cancer. Support Care Cancer (2005) 0.87
Effectiveness of health-related quality-of-life measurement in clinical practice: a prospective, randomized controlled trial in patients with chronic liver disease and their physicians. Qual Life Res (2008) 0.87
Towards the Implementation of Quality of Life Monitoring in Daily Clinical Routine: Methodological Issues and Clinical Implication. Breast Care (Basel) (2009) 0.87
Development and validation of a new patient-reported outcome measure for patients with pressure ulcers: the PU-QOL instrument. Health Qual Life Outcomes (2013) 0.87
How does patient-clinician information engagement influence self-reported cancer-related problems?: findings from a longitudinal analysis. Cancer (2011) 0.87
When using patient-reported outcomes in clinical practice, the measure matters: a randomized controlled trial. J Oncol Pract (2014) 0.87
Issues patients would like to discuss at their review consultation: variation by early and late stage oral, oropharyngeal and laryngeal subsites. Eur Arch Otorhinolaryngol (2012) 0.86
Distinct contributions of adverse childhood experiences and resilience resources: a cohort analysis of adult physical and mental health. Soc Work Health Care (2014) 0.86
Integration of palliative medicine into routine oncological care: what does the evidence show us? J Oncol Pract (2011) 0.86
Conducting routine fatigue assessments for use in clinical oncology practice: patient and provider perspectives. Support Care Cancer (2007) 0.86
Metrics to assess quality of life after management of early-stage lung cancer. Cancer J (2011) 0.86
Quality of life in patients with chordomas/chondrosarcomas during treatment with proton beam therapy. J Radiat Res (2013) 0.85
Psychological factors associated with head and neck cancer treatment and survivorship: evidence and opportunities for behavioral medicine. J Consult Clin Psychol (2012) 0.85
Inadequate symptom control in advanced cancer patients across Europe. Support Care Cancer (2010) 0.85
Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet (2008) 15.43
Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet (2005) 14.64
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med (2003) 8.93
Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol (2007) 7.75
Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet (2011) 7.50
Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst (2008) 5.82
Approaching a state shift in Earth's biosphere. Nature (2012) 5.25
Evaluating the rationale of the osteopathic internship. J Am Osteopath Assoc (2004) 4.02
Should we expect population thresholds for wildlife disease? Trends Ecol Evol (2005) 3.17
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96
Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer. Cancer Res (2006) 2.87
The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis. Blood (2011) 2.69
Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection. Clin Cancer Res (2013) 2.45
Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics (2004) 2.43
Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics (2003) 2.17
Lymph nodes, tumor deposits, and TNM: are we getting better? J Clin Oncol (2011) 2.09
The debt of nations and the distribution of ecological impacts from human activities. Proc Natl Acad Sci U S A (2008) 1.86
Impact of pressure ulcers on quality of life in older patients: a systematic review. J Am Geriatr Soc (2009) 1.83
Housekeeping proteins: a preliminary study illustrating some limitations as useful references in protein expression studies. Proteomics (2005) 1.69
Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol (2010) 1.68
Biodiversity scales from plots to biomes with a universal species-area curve. Ecol Lett (2009) 1.68
Executive function across the life span. Acta Psychol (Amst) (2004) 1.67
Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation. Kidney Int (2013) 1.61
Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma. Clin Cancer Res (2009) 1.49
Evaluation of five search strategies in retrieving qualitative patient-reported electronic data on the impact of pressure ulcers on quality of life. J Adv Nurs (2010) 1.47
Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clin Chem (2005) 1.46
Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychol (2009) 1.45
Cost effectiveness of pre-operative gonadotrophin releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy. BJOG (2002) 1.44
Tumor infection by oncolytic reovirus primes adaptive antitumor immunity. Clin Cancer Res (2008) 1.44
Communication about sexual problems and sexual concerns in ovarian cancer: a qualitative study. West J Med (2002) 1.40
Factor analysis of the Hospital Anxiety and Depression Scale from a large cancer population. Psychol Psychother (2002) 1.40
Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting. J Pathol (2009) 1.38
A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Hum Mol Genet (2011) 1.34
Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme. J Cell Sci (2004) 1.29
The impact of postoperative complications on long-term quality of life after curative colorectal cancer surgery. Ann Surg (2014) 1.27
Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. Cancer Res (2003) 1.26
Clinical evaluation of magnetic resonance imaging in coronary heart disease: the CE-MARC study. Trials (2009) 1.26
Reciprocal human dendritic cell-natural killer cell interactions induce antitumor activity following tumor cell infection by oncolytic reovirus. J Immunol (2009) 1.25
Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer. Clin Cancer Res (2007) 1.25
A Rasch and factor analysis of the Functional Assessment of Cancer Therapy-General (FACT-G). Health Qual Life Outcomes (2007) 1.19
The clinical value of quality of life assessment in oncology practice-a qualitative study of patient and physician views. Psychooncology (2008) 1.18
Mining the archival formalin-fixed paraffin-embedded tissue proteome: opportunities and challenges. Mol Biosyst (2008) 1.18
CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden. Br J Haematol (2008) 1.17
Autocrine regulation of human urothelial cell proliferation and migration during regenerative responses in vitro. Exp Cell Res (2005) 1.13
Internalization of oncolytic reovirus by human dendritic cell carriers protects the virus from neutralization. Clin Cancer Res (2011) 1.12
Psychosocial care for cancer patients in primary care? Recognition of opportunities for cancer care. Fam Pract (2004) 1.11
Anthropogenic refugia ameliorate the severe climate-related decline of a montane mammal along its trailing edge. Proc Biol Sci (2012) 1.10
Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations. Am J Pathol (2002) 1.10
Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma. Proteomics (2006) 1.10
Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: secondary outcomes of a randomised controlled trial. Eur J Cancer (2010) 1.09
Impact of patient-reported outcomes in oncology: a longitudinal analysis of patient-physician communication. J Clin Oncol (2011) 1.09
Proteomic analysis of formalin-fixed paraffin-embedded renal tissue samples by label-free MS: assessment of overall technical variability and the impact of block age. Proteomics Clin Appl (2013) 1.08
Renal cancer biomarkers: the promise of personalized care. BMC Med (2012) 1.08
Initial development and validation of a novel extraction method for quantitative mining of the formalin-fixed, paraffin-embedded tissue proteome for biomarker investigations. J Proteome Res (2010) 1.07
Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials. Eur J Cancer (2008) 1.07
Social support: gender differences in cancer patients in the United Kingdom. Cancer Nurs (2006) 1.06
Communication strategies for enhancing understanding of the behavioral implications of genetic and biomarker tests for disease risk: the role of coherence. J Behav Med (2011) 1.05
Integrated multi-level quality control for proteomic profiling studies using mass spectrometry. BMC Bioinformatics (2008) 1.04
A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analyses. Proteomics (2011) 1.02
Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy? Clin Cancer Res (2011) 1.00
Closely related mycobacterial strains demonstrate contrasting levels of efficacy as antitumor vaccines and are processed for major histocompatibility complex class I presentation by multiple routes in dendritic cells. Infect Immun (2005) 0.99
Stroke rehabilitation services to accelerate hospital discharge and provide home-based care: an overview and cost analysis. Pharmacoeconomics (2002) 0.96
Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinoma. Int J Cancer (2005) 0.96
Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival. Clin Cancer Res (2008) 0.96
Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent. PLoS One (2012) 0.95
Temporal dynamics and decay of putatively allochthonous and autochthonous viral genotypes in contrasting freshwater lakes. Appl Environ Microbiol (2012) 0.94
The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell line. Melanoma Res (2003) 0.92
Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma. Proteomics (2006) 0.92
Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line. Endocr Relat Cancer (2014) 0.92
Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison. Proteomics (2009) 0.91
Positive relationship between support group attendance and one-year postoperative weight loss in gastric banding patients. Surg Obes Relat Dis (2010) 0.91
Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int (2013) 0.90
Are stroke units cost effective? Evidence from a New Zealand stroke incidence and population-based study. Int J Stroke (2011) 0.90
Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladder. J Pathol (2002) 0.90
Impact of pre-analytical factors on the proteomic analysis of formalin-fixed paraffin-embedded tissue. Proteomics Clin Appl (2013) 0.89
Proteomic identification of differentially expressed plasma membrane proteins in renal cell carcinoma by stable isotope labelling of a von Hippel-Lindau transfectant cell line model. Proteomics (2009) 0.89
Serum biomarker discovery in renal cancer using 2-DE and prefractionation by immunodepletion and isoelectric focusing; increasing coverage or more of the same? Proteomics (2008) 0.87
Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM). Blood Rev (2013) 0.87
Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ions. Ann Clin Biochem (2011) 0.87
Development of a conceptual framework of health-related quality of life in pressure ulcers: a patient-focused approach. Int J Nurs Stud (2010) 0.87
Development and validation of a new patient-reported outcome measure for patients with pressure ulcers: the PU-QOL instrument. Health Qual Life Outcomes (2013) 0.87
The Social Difficulties Inventory (SDI): development of subscales and scoring guidance for staff. Psychooncology (2011) 0.87
Key clinical issues in renal cancer: a challenge for proteomics. World J Urol (2007) 0.87
Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers. Nat Rev Urol (2013) 0.87
The cost effectiveness of genetic testing for CYP2C19 variants to guide thienopyridine treatment in patients with acute coronary syndromes: a New Zealand evaluation. Pharmacoeconomics (2012) 0.86
Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma. Proteomics (2003) 0.86
Development of an advanced database for clinical trials integrated with an electronic patient record system. Comput Biol Med (2011) 0.86
Health economics in drug development: efficient research to inform healthcare funding decisions. Eur J Cancer (2010) 0.85
Proteomic profiling using mass spectrometry--does normalising by total ion current potentially mask some biological differences? Proteomics (2008) 0.85
The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis. J Natl Cancer Inst (2002) 0.85
Identification of new genetic risk factors for prostate cancer. Asian J Androl (2008) 0.85
A clinical study comparing the efficacy of light activated in-surgery whitening versus in-surgery whitening without light activation. J Dent (2013) 0.84